Scimega Researchis Canadian specialty CRO with a singular focus on oncology. They play a vital role in improving the speed and efficiency of oncology clinical research through a deep understanding of the needs of sponsors, investigators and patients. They believe that the rise of targeted therapies and personalized medicine should not increase operational complexity or compromise the efficiency of clinical trials.
|Number of employees||11-50 employees|
Scimega was founded to meet the industry’s need for superior clinical trial services in the complex field of oncology research. In 1997, they were trail blazers, and most sponsors didn’t understand the importance of their unique business model. Since then many have come to value their expertise.
In 2008, they introduced the Reverse Feasibility Program – a collaborative approach that connects biotech sponsors with investigators to meet the needs of cancer patients, and the scientific interests of investigators while allowing sponsors to meet their timelines and make quicker go/no-go drug development decisions.
With 20+ years of dedicated oncology experience under their belts, their service offering is now finely tuned at a time when their clients need them most.
- Site Selection & Accelerated Study Start-Up
- Health Canada Regulatory Strategy
- Provincial Ethics Approval Strategy(IRB/REB)
- Clinical Monitoring
- Country Oversight
Top 5 Recent Tweets